| Entry |
|
|---|
| Name |
Carazolol (INN);
Conducton (TN);
Suacron [veterinary] (TN) |
|---|
| Formula |
C18H22N2O2
|
|---|
| Exact mass |
298.1681
|
|---|
| Mol weight |
298.38
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG01462 beta2-Adrenergic receptor antagonist
|
|---|
| Efficacy |
Stress management agent (veterinary), beta2-Adrenergic receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG01462 beta2-Adrenergic receptor antagonist
D07608 Carazolol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D07608 Carazolol (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 C1b C 20.9300 -15.4700
2 C1c C 22.1900 -16.1700
3 C1b C 23.3800 -15.4700
4 N1b N 24.5700 -16.1700
5 C1c C 25.8300 -15.4700
6 C1a C 27.0200 -16.1700
7 O1a O 22.1900 -17.5700
8 C1a C 25.8300 -14.0700
9 O2a O 19.7293 -16.1899
10 C8y C 19.7293 -17.5899
11 C8y C 18.5335 -18.2801
12 C8y C 18.5333 -19.6801
13 C8x C 19.7457 -20.3803
14 C8x C 20.9415 -19.6901
15 C8x C 20.9416 -18.2901
16 C8y C 17.2020 -17.8473
17 C8y C 16.3790 -18.9799
18 N4x N 17.2018 -20.1126
19 C8x C 16.6328 -16.5683
20 C8x C 15.2404 -16.4218
21 C8x C 14.4174 -17.5543
22 C8x C 14.9867 -18.8334
BOND 24
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 2 7 1
7 5 8 1
8 1 9 1
9 9 10 1
10 10 11 2
11 11 12 1
12 12 13 2
13 13 14 1
14 14 15 2
15 10 15 1
16 11 16 1
17 16 17 1
18 17 18 1
19 12 18 1
20 16 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 17 22 2
|
|---|
